Assenagon Asset Management S.A. Has $783,000 Stock Position in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Assenagon Asset Management S.A. boosted its position in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 357.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 30,247 shares of the company's stock after acquiring an additional 23,639 shares during the quarter. Assenagon Asset Management S.A. owned 0.12% of Establishment Labs worth $783,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. JW Asset Management LLC grew its stake in shares of Establishment Labs by 0.8% during the first quarter. JW Asset Management LLC now owns 3,142,485 shares of the company's stock worth $211,772,000 after buying an additional 25,000 shares during the last quarter. Nantahala Capital Management LLC grew its stake in shares of Establishment Labs by 1.2% during the first quarter. Nantahala Capital Management LLC now owns 2,149,201 shares of the company's stock worth $144,835,000 after buying an additional 25,965 shares during the last quarter. Brown Advisory Inc. grew its stake in shares of Establishment Labs by 0.8% during the third quarter. Brown Advisory Inc. now owns 1,482,180 shares of the company's stock worth $72,731,000 after buying an additional 11,780 shares during the last quarter. Cowen AND Company LLC grew its stake in shares of Establishment Labs by 18.1% in the third quarter. Cowen AND Company LLC now owns 1,141,172 shares of the company's stock worth $55,997,000 after purchasing an additional 175,000 shares during the last quarter. Finally, Iron Triangle Partners LP grew its stake in shares of Establishment Labs by 26.6% in the second quarter. Iron Triangle Partners LP now owns 537,906 shares of the company's stock worth $36,906,000 after purchasing an additional 112,906 shares during the last quarter. 72.91% of the stock is owned by institutional investors.

Analysts Set New Price Targets

ESTA has been the topic of several recent analyst reports. Mizuho boosted their target price on shares of Establishment Labs from $50.00 to $65.00 and gave the company a "buy" rating in a report on Monday, April 1st. Citigroup boosted their target price on shares of Establishment Labs from $49.00 to $60.00 and gave the company a "buy" rating in a report on Wednesday. Stephens restated an "overweight" rating and issued a $47.00 target price on shares of Establishment Labs in a report on Thursday, January 11th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Establishment Labs from $46.00 to $53.00 and gave the company an "overweight" rating in a report on Thursday, February 29th. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has an average rating of "Buy" and an average target price of $63.33.

Establishment Labs Stock Performance

Shares of ESTA stock traded up $1.46 during trading on Friday, reaching $54.16. 265,337 shares of the company's stock traded hands, compared to its average volume of 338,690. The company has a market capitalization of $1.47 billion, a P/E ratio of -17.82 and a beta of 1.24. The company has a current ratio of 3.06, a quick ratio of 1.67 and a debt-to-equity ratio of 10.26. The firm's 50-day moving average is $44.28 and its 200 day moving average is $35.89. Establishment Labs Holdings Inc. has a 1 year low of $16.96 and a 1 year high of $79.88.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its earnings results on Wednesday, February 28th. The company reported ($0.79) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.95) by $0.16. The business had revenue of $31.60 million for the quarter, compared to analysts' expectations of $31.44 million. Establishment Labs had a negative net margin of 47.53% and a negative return on equity of 357.81%. The business's revenue for the quarter was down 27.9% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.55) EPS. Equities research analysts expect that Establishment Labs Holdings Inc. will post -1.58 EPS for the current year.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.